secwatch.observer — SEC 8-K summary
======================================

Issuer:     SERA PROGNOSTICS, INC. (SERA)
CIK:        0001534969
Form:       8-K
Filed at:   2026-06-30T20:09:46+00:00
Accession:  0001534969-26-000035
Event type: leadership
Sentiment:  neutral
Materiality: 0.45
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sera Prognostics appoints Mark Capone to Board of Directors effective July 1, 2026
--------------------------------------------------------------------------------

- Mark Capone appointed as Class II director effective July 1, 2026, and to the Compensation Committee.
- Capone is former CEO of Myriad Genetics with 40+ years in diagnostics and life sciences.
- Initial equity award of $167,072 (or 150,000 option equivalents) granted July 10, 2026, with multi-year vesting.
- Annual equity awards of $88,359 (or 75,000 option equivalents) after each annual meeting, vesting over one year.
- Board determined Capone is independent under Nasdaq rules.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1534969/000153496926000035/0001534969-26-000035-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1534969/000153496926000035/sera-20260625.htm
  HTML page:      https://secwatch.observer/filing/0001534969-26-000035

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer